PlainRecalls
FDA Drug Moderate Class II Ongoing

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Reported: April 26, 2023 Initiated: April 13, 2023 #D-0538-2023

Product Description

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Reason for Recall

Lack of assurance of sterility.

Details

Units Affected
45 vials
Distribution
MS only
Location
Hattiesburg, MS

Frequently Asked Questions

What product was recalled?
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402. Recalled by Pharmacy Plus, Inc. dba Vital Care Compounder. Units affected: 45 vials.
Why was this product recalled?
Lack of assurance of sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 26, 2023. Severity: Moderate. Recall number: D-0538-2023.